Marshak Richard sold $1K of TLSI
Marshak Richard (Chief Commercial Officer) sold 325 shares of TriSalus Life Sciences, Inc. (TLSI) at $4.39 on 2026-10-05.
How this was made
The 30-second read
Why it matters
The transaction is too small to affect price materially, but it confirms ongoing insider activity.
Market read
Routine insider sale with minimal market impact.
What to watch
Potential upcoming clinical data releases could change perception of insider activity.
Background
Form 4 filing provides the first public disclosure of the insider's share sale.
Ticker impact
SEC Form 4 disclosed CCO Richard Marshak sold 325 shares for $1,426.75 on Oct 5.
likely slight pressure as market prices in the small sale
Sale size is trivial relative to holdings and market cap; no material impact expected.
Market effects
None; isolated insider transaction.
None; micro‑cap US biotech.
None
Counterpoint
Even small insider sells can signal concerns, but no corroborating evidence here.
Key entities
- CompanyTriSalus Life Sciences, Inc.
US‑listed biotech (NASDAQ: TLSI).
- PersonRichard Marshak
Chief Commercial Officer of TLSI.